Anandamide extends platelets survival through CB1-dependent Akt signaling

Cellular and Molecular Life Sciences

Volumn 67, Issue 4, 2010, Pages 601-610

  Catani, Maria Valeria ^a   Gasperi, Valeria ^a,b   Evangelista, Daniela ^a   Agrò, Alessandro Finazzi ^a   Avigliano, Luciana ^a   MacCarrone, Mauro ^b,c  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^c UNIVERSITY OF TERAMO   (Italy)

Author keywords

Bak; Bcl xL; Cell death; Endocannabinoid system; Signal transduction; Thrombocytopenia

Indexed keywords

ANANDAMIDE; CANNABINOID 1 RECEPTOR; CASPASE; METHANANDAMIDE; PROTEIN BAD; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN KINASE B; AMIDE; ARACHIDONIC ACID DERIVATIVE; CANNABINOID;

ARTICLE; BIOLOGICAL RHYTHM; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVATION; HEAT STRESS; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TEMPERATURE DEPENDENCE; THROMBOCYTE LIFESPAN; WESTERN BLOTTING; ADULT; BLOOD STORAGE; CELL CULTURE; CELL SURVIVAL; DRUG EFFECT; LABORATORY DIAGNOSIS; METABOLISM; PHYSIOLOGY; THROMBOCYTE;

ADULT; ARACHIDONIC ACIDS; BLOOD PLATELETS; BLOOD PRESERVATION; CANNABINOIDS; CELL SURVIVAL; CELLS, CULTURED; HUMANS; POLYUNSATURATED ALKAMIDES; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, CANNABINOID, CB1; SIGNAL TRANSDUCTION; SPECIMEN HANDLING;

EID: 75649149906     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-009-0198-9     Document Type: Article

References (40)

1. Bari M, Battista N, Fezza F, Gasperi V, Maccarrone M (2006) New insights into endocannabinoid degradation and its therapeutic potential. Mini Rev Med Chem 6:257-268
2. Di Marzo V (2008) Targeting the endocannabinoid system: to enhance or reduce? Nat. Rev. Drug Discov. 7:438-455
3. Battista N, Gasperi V, Fezza F, Maccarrone M (2005) The anandamide membrane transporter and the therapeutic implications of its inhibition. Therapy 2:141-150
4. McKinney MK, Cravatt BF (2005) Structure and function of fatty acid amide hydrolase. Annu Rev Biochem 74:411-432
5. Katona I, Freund TF (2008) Endocannabinoid signaling as a synaptic circuit breaker in neurological disease. Nat Med 14:923-930
6. Shimizu T (2009) Lipid mediators in health and disease: enzymes and receptors as therapeutic targets for the regulation of immunity and inflammation. Annu Rev Pharmacol Toxicol 49:123-150
7. Maccarrone M, Finazzi-Agrò A (2003) The endocannabinoid system, anandamide and the regulation of mammalian cell apoptosis. Cell Death Differ 10:946-955
8. Pushkarev VM, Kovzun OI, Tronko MD (2008) Antineoplastic and apoptotic effects of cannabinoids. N-acylethanolamines: protectors or killers? Exp Oncol 30:6-21
9. Bari M, Battista N, Fezza F, Finazzi-Agrò A, Maccarrone M (2005) Lipid rafts control signaling of type-1 cannabinoid receptors in neuronal cells. Implications for anandamide-induced apoptosis. J Biol Chem 280:12212-12220
10. Bentzen PJ, Lang F (2007) Effect of anandamide on erythrocyte survival. Cell Physiol Biochem 20:1033-1042
11. Siegmund SV, Qian T, de Minicis S, Harvey-White J, Kunos G, Vinod KY, Hungund B, Schwabe RF (2007) The endocannabi-noid 2-arachidonoyl glycerol induces death of hepatic stellate cells via mitochondrial reactive oxygen species. FASEB J 21:2798-2806
12. Dobrosi N, Tóth BI, Nagy G, Dózsa A, Géczy T, Nagy L, Zouboulis CC, Paus R, Kovács L, Bíró T (2008) Endocannabi-noids enhance lipid synthesis and apoptosis of human sebocytes via cannabinoid receptor-2-mediated signaling. FASEB J 22:3685-3695
13. Turco MY, Matsukawa K, Czernik M, Gasperi V, Battista N, Della Salda L, Scapolo PA, Loi P, Maccarrone M, Ptak G (2008) High levels of anandamide, an endogenous cannabinoid, block the growth of sheep preimplantation embryos by inducing apoptosis and reversible arrest of cell proliferation. Hum Reprod 23:2331-2338
14. Gómez del Pulgar T, Velasco G, Guzmán M (2000) The CB1 cannabinoid receptor is coupled to the activation of protein kinase B/Akt. Biochem J 347:369-373
15. Viscomi MT, Oddi S, Latini L, Pasquariello N, Florenzano F, Bernardi G, Molinari M, Maccarrone M (2009) Selective CB2 receptor agonism protects central neurons from remote axotomy-induced apoptosis through the PI3K/Akt pathway. J Neurosci 29:4564-4570
16. Baldassarri S, Bretoni A, Bagarotti A, Sarasso C, Zanfa M, Catani MV, Avigliano L, Maccarrone M, Torti M, Sinigaglia F (2008) The endocannabinoid 2-arachidonoylglycerol activates human platelets through non-CB1/CB2 receptors. J Thromb Haemost 6:1772-1779
17. Malorni W, Bari M, Straface E, Battista N, Matarrese P, Finazzi-Agrò A, Del Principe D, Maccarrone M (2004) Morphological evidence that 2-arachidonoylglycerol is a true agonist of human platelets. Thromb Haemost 92:1159-1161
18. Maccarrone M, Bari M, Menichelli A, Del Principe D, Finazzi-Agrò A (1999) Anandamide activates human platelets through a pathway independent of the arachidonate cascade. FEBS Lett 447:277-282
19. Maccarrone M, Bari M, Del Principe D, Finazzi-Agrò A (2003) Activation of human platelets by 2 arachidonoylglycerol is enhanced by serotonin. Thromb Haemost 89:340-347
20. Italiano JE, Hartwig JH (2007) Megakaryocyte development and platelet formation. In: Michelson AD (ed) Platelets. Elsevier, San Diego, pp 23-44
21. Battinelli EM, Hartwig JH, Italiano JE Jr (2007) Delivering new insight into the biology of megakaryopoiesis and thrombopoiesis. Curr Opin Hematol 14:419-426
22. Catani MV, Fezza F, Baldassarri S, Gasperi V, Bretoni A, Pasquariello N, Finazzi-Agrò A, Sinigaglia F, Avigliano L, Maccarrone M (2009) Expression of the endocannabinoid system in the bi-potential HEL cell line: commitment to the mega-karyoblastic lineage by 2-arachidonoylglycerol. J Mol Med 87:65-74
23. Bertino AM, Qi XQ, Li J, Xia Y, Kuter DJ (2003) Apoptotic markers are increased in platelets stored at 37 degrees C. Transfusion 43:857-866
24. Mason KD, Carpinelli MR, Fletcher JI, Collinge JE, Hilton AA, Ellis S, Kelly PN, Ekert PG, Metcalf D, Roberts AW, Huang DC, Kile BT (2007) Programmed anuclear cell death delimits platelet life span. Cell 128:1173-1186
25. Minn AJ, Kettlun CS, Liang H, Kelekar A, Vander Heiden MG, Chang BS, Fesik SW, Fill M, Thompson CB (1999) Bcl-xL regulates apoptosis by heterodimerization-dependent and-independent mechanisms. EMBO J 18:632-643
26. Degenhardt K, Sundararajan R, Lindsten T, Thompson C, White E (2002) Bax and Bak independently promote cytochrome C release from mitochondria. J Biol Chem 277:14127-14134
27. Gasperi V, Fezza F, Pasquariello N, Bari M, Oddi S, Finazzi-Agrò A, Maccarrone M (2007) Endocannabinoids in adipocytes during differentiation and their role in glucose uptake. Cell Mol Life Sci 64:219-229
28. Szabadi E (1977) A model of two functionally antagonistic receptor populations activated by the same agonist. J Theor Biol 69:101-112
29. Brown F, Graham JD, Taha SA (1973) Fade and desensitisation in guinea-pig ileum and vas deferens. Eur J Pharmacol 22:64-74
30. Datta SR, Brunet A, Greenberg ME (1999) Cellular survival: a play in three Akts. Genes Dev 13:2905-2927
31. Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME (1997) Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91:231-241
32. Tonon G, Luo X, Greco NJ, Chen W, Shi Y, Jamieson GA (2002) Weak platelet agonists and U46619 induce apoptosis-like events in platelets, in the absence of phosphatidylserine exposure. Thromb Res 107:345-350
33. Brown SB, Clarke MC, Magowan L, Sanderson H, Savill JJ (2000) Constitutive death of platelets leading to scavenger receptor-mediated phagocytosis. A caspase-independent cell clearance program. Biol Chem 275:5987-5996
34. Maccarrone M, Bari M, Menichelli A, Giuliani E, Del Principe D, Finazzi-Agrò A (2001) Human platelets bind and degrade 2-arachidonoylglycerol, which activates these cells through a cannabinoid receptor. Eur J Biochem 268:819-825
35. Centonze D, Battistini L, Maccarrone M (2008) The endocan-nabinoid system in peripheral lymphocytes as a mirror of neuroinflammatory diseases. Curr Pharm Des 14:2370-2382
36. Giuffrida A, Piomelli D (1998) Isotope dilution GC/MS determination of anandamide and other fatty acylethanolamides in rat blood plasma. FEBS Lett 422:373-376
37. Wagner JA, Varga K, Ellis EF, Rzigalinski BA, Martin BR, Kunos G (1997) Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock. Nature 390:518-521
38. Deutsch DG, Goligorsky MS, Schmid PC, Krebsbach RJ, Schmid HH, Das SK, Dey SK, Arreaza G, Thorup C, Stefano G, Moore LC (1997) Production and physiological actions of anandamide in the vasculature of the rat kidney. J Clin Invest 100:1538-1546
39. Valk P, Verbakel S, Vankan Y, Hol S, Mancham S, Ploemacher R, Mayen A, Löwenberg B, Delwel R (1997) Anandamide, a natural ligand for the peripheral cannabinoid receptor is a novel synergistic growth factor for hematopoietic cells. Blood 90:1448-1457
40. Kozuma Y, Kojima H, Yuki S, Suzuki H, Nagasawa T (2007) Continuous expression of Bcl-xL protein during megakaryopoi-esis is post-translationally regulated by thrombopoietin-mediated Akt activation, which prevents the cleavage of Bcl-xL. J Thromb Haemost 5:1274-1282